Urilax(Flavoxate Hydrochloride)

Therapeutic Group: Urological

Presentation

Urilax 100: Each tablet contains Flavoxate Hydrochloride BP 100 mg .

Urilax 200: Each tablet contains Flavoxate Hydrochloride BP 200 mg.

Description

Flavoxate is a synthetic urinary tract spasmolytic. Flavoxate counteracts smooth muscle spasm of the urinary tract and exerts its effect directly on the muscle. It relaxes the muscles of the urinary tract.

Indications

Flavoxate is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis and urethrocystitis.

Dosage & Administration

Adults and children over 12 years of age: Each tablet (100 mg or 200 mg) 3 times a day. With improvement of symptoms, the dose may be reduced.
Pediatric Use: Safety and effectiveness in children below the age of 12 years have not been established.

Side Effects

Gastrointestinal: Nausea, vomiting, dry mouth.
CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness.
Hematologic: Leukopenia (which is reversible upon discontinuation of the drug).
Cardiovascular: Tachycardia and palpitation.
Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia.
Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.

Precautions

Flavoxate should be given cautiously in patients with suspected glaucoma

Use in Pregnancy & Lactation

Pregnancy: Pregnancy Category B. This drug should be used during pregnancy only if clearly needed.
Nursing Mothers: It is not known whether this drug is excreted in human milk. Caution should be exercised when flavoxate is administered to a nursing woman.

Commercial Pack

Urilax 100: Each box contains 3 blister strips of 10 tablets.
Urilax 200: Each box contains 3 blister strips of 10 tablets.